deflazacort has been researched along with Giant Cell Arteritis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Devogelaer, JP; Gennari, C | 1 |
Blanco, R; González-Gay, MA; Monte, R; Santiago, J | 1 |
Belmatoug, N; Cacoub, P; Chemlal, K; Cohen, P; De Gennes, C; Khalifa, P; Piette, JC; Verdoncq, B; Wechsler, B; Ziza, JM | 1 |
1 trial(s) available for deflazacort and Giant Cell Arteritis
Article | Year |
---|---|
Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcium; Double-Blind Method; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prednisone; Pregnenediones; Prospective Studies; Spinal Fractures; Treatment Outcome; Vitamin D | 2001 |
2 other study(ies) available for deflazacort and Giant Cell Arteritis
Article | Year |
---|---|
Deflazacort in giant cell arteritis.
Topics: Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcifediol; Dietary Supplements; Dose-Response Relationship, Drug; Giant Cell Arteritis; Humans; Prednisone; Pregnenediones; Randomized Controlled Trials as Topic | 2002 |
Low-dose corticosteroids and blindness in giant cell arteritis.
Topics: Aged; Anti-Inflammatory Agents; Blindness; Dose-Response Relationship, Drug; Giant Cell Arteritis; Humans; Male; Prednisone; Pregnenediones | 1996 |